WeVote

Bill

Bill

S 421

Defund the Wuhan Institute of Virology Act

118th Congress Introduced by Joni Ernst

Prohibits all U.S. federal funding to China's Wuhan Institute of Virology over biosafety and COVID-19 origin concerns.

Introduced in Senate
0
WeVote Research Nonpartisan
Bill Summary · S 421

Legislative bill overview

S. 421 would prohibit the U.S. government from providing any funding, grants, or cooperative agreements to the Wuhan Institute of Virology (WIV) in China. The bill represents a legislative effort to completely sever U.S. financial support to this specific research institution, reflecting concerns about biosafety practices and the origins of COVID-19.

Why is this important

This bill addresses ongoing debates about U.S. scientific funding relationships with Chinese institutions amid unresolved questions about COVID-19's origins. The measure reflects broader tensions in U.S.-China relations and raises questions about how Congress exercises oversight of federal research funding, particularly regarding biosecurity concerns.

Potential points of contention

  • Origins debate: The bill's premises depend on contested claims about WIV's role in COVID-19's emergence, which remains scientifically unresolved and politically polarized
  • Scientific collaboration: Critics argue defunding may reduce transparency and U.S. monitoring ability at the institution, while supporters contend biosafety risks justify the ban
  • Broader implications: The bill could set precedent for restricting international scientific partnerships based on geopolitical concerns rather than research merit alone
  • Existing restrictions: The U.S. already has significant limitations on WIV funding; the practical impact of this bill depends on whether current funding channels exist that aren't already prohibited

Compiled from official sources — confirm details with the bill’s official record.

Sign in to ask a question.